A detailed history of Health Cor Management, L.P. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Health Cor Management, L.P. holds 367,765 shares of BMRN stock, worth $24.5 Million. This represents 35.97% of its overall portfolio holdings.

Number of Shares
367,765
Previous 759,038 51.55%
Holding current value
$24.5 Million
Previous $64.3 Million 40.85%
% of portfolio
35.97%
Previous 8.05%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$80.93 - $108.63 $31.7 Million - $42.5 Million
-391,273 Reduced 51.55%
367,765 $38.1 Million
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $1.49 Million - $1.75 Million
18,090 Added 2.44%
759,038 $64.3 Million
Q2 2022

Aug 15, 2022

SELL
$71.48 - $86.85 $2.01 Million - $2.44 Million
-28,068 Reduced 3.65%
740,948 $61.4 Million
Q1 2022

May 16, 2022

BUY
$74.28 - $92.69 $45.3 Million - $56.5 Million
609,696 Added 382.69%
769,016 $59.3 Million
Q4 2021

Feb 14, 2022

BUY
$71.72 - $91.47 $11.4 Million - $14.6 Million
159,320 New
159,320 $14.1 Million
Q2 2021

Aug 16, 2021

SELL
$75.51 - $84.79 $17.2 Million - $19.3 Million
-227,450 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$74.73 - $90.69 $391,585 - $475,215
5,240 Added 2.36%
227,450 $17.2 Million
Q4 2020

Feb 16, 2021

BUY
$72.61 - $90.2 $15.1 Million - $18.7 Million
207,610 Added 1421.99%
222,210 $19.5 Million
Q3 2020

Nov 16, 2020

BUY
$71.87 - $131.03 $1.05 Million - $1.91 Million
14,600 New
14,600 $1.11 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Health Cor Management, L.P. Portfolio

Follow Health Cor Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Health Cor Management, L.P. with notifications on news.